Analytical Data
-
Gene name
LIX1
- Application
-
Alternative Names
C5orf11; Limb expression 1; LIX1; Lix1 homolog (chicken); LIX1_HUMAN; Protein limb expression 1 homolog
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8N485
-
Expression Region
1-282aa
-
AA Sequence
MDITLESLRHIIAQVLPHRDPALVFKDLNVVSMLQEFWESKQQQKAAFPSEGVVVYESLPAPGPPFVSYVTLPGGSCFGNFQCCLSRAEARRDAAKVALINSLFNELPSRRITKEFIMESVQEAVASTSGTLDDADDPSTSVGAYHYMLESNMGKTMLEFQELMTIFQLLHWNGSLKALRETKCSRQEVISYYSQYSLDEKMRSHMALDWIMKERDSPGIVSQELRMALRQLEEARKAGQELRFYKEKKEILSLALTQICSDPDTSSPSDDQLSLTALCGYH
-
Molecular Weight
58.2 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
LIX1, or Lipocortin-1, is a member of the Lipocortin family, which is involved in various biological processes, including inflammatory responses, cell signaling, and apoptosis. The protein is known to interact with phospholipids and modulate calcium-dependent cellular activities, making it a critical player in immune response regulation. Research into LIX1 has gained momentum due to its potential link to various diseases, including autoimmune disorders and cancer. The recombinant expression of LIX1 has been undertaken to produce sufficient quantities for further biochemical and functional studies, enabling researchers to elucidate its mechanism of action and role in cellular pathways. Understanding LIX1's structure and function through recombinant protein studies could lead to novel therapeutic strategies targeting its signaling pathways, offering hope for innovative treatments in inflammatory diseases and tumors. Moreover, the exploration of LIX1's interactions with other cellular molecules may provide insights into its broader implications in health and disease, thereby highlighting its potential as a biomarker or drug target. As such, the study of LIX1 recombinant protein continues to be a vital area of research in molecular biology and pharmacology.
